Rocket Pharmaceuticals Issues Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I

  • Jonathan Schwartz,

Press/Media

Period24 Oct 2021

Media coverage

1

Media coverage

  • TitleRocket Pharmaceuticals Issues Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I
    Media name/outletProfessional Services Close-Up
    Country/TerritoryUnited States
    Date24/10/21
    PersonsJonathan Schwartz,